Skip to main content

Table 2 Characteristics of study population

From: Screening efficacy of PhA and MNA-SF in different stages of sarcopenia in the older adults in community

Events

Control group

(n = 120)

Possible sarcopenia

(n = 106)

Pre-sarcopenia

(n = 12)

Sarcopenia (common type)

(n = 17)

Severe sarcopenia

(n = 15)

P

Gender

     

0.026

 Male

51(42.5)

28(26.4)

6(50.0)

5(29.4)

2(13.3)

 

 Female

69(57.5)

78(73.6)

6(50.0)

12(70.6)

13(86.7)

 

Family average monthly income

     

0.895

  ≤ 3000

6(5.0)

3(2.8)

0(0.0)

0(0.0)

0(0.0)

 

 3001–6000

69(57.5)

60(56.6)

8(66.7)

12(70.6)

9(60.0)

 

 6001–9000

26(21.7)

30(28.3)

1(8.3)

3(17.6)

3(20.0)

 

 >9000

19(15.8)

13(12.3)

3(25.0)

2(11.8)

3(20.0)

 

Education level

     

0.322

 Junior high and primary school

29(24.2)

32(30.2)

7(58.3)

5(29.4)

2(13.3)

 

 High/secondary specialized school

31(25.8)

30(28.3)

2(16.7)

1(5.9)

5(33.3)

 

 Junior college

36(30.0)

26(24.5)

2(16.7)

5(29.4)

5(33.3)

 

 Bachelor degree or above

24(20.0)

18(17.0)

1(8.3)

6(35.3)

3(20.0)

 

Pre-retirement occupational

     

0.314

 Public official

43(35.8)

24(22.6)

5(41.7)

4(23.5)

2(13.3)

 

 technician

42(35.0)

44(41.5)

3(25.0)

7(41.2)

9(60.0)

 

 else

35(29.2)

38(35.8)

4(33.3)

6(35.3)

4(26.7)

 

Marital status

     

0.006

 Married

106(88.3)

86(81.1)

10(83.3)

14(82.4)

7(46.7)

 

 else

14(11.7)

20(18.9)

2(16.7)

3(17.6)

8(53.3)

 

Living situation

     

0.091

 Alone

10(8.3)

12(11.3)

1(8.3)

1(5.9)

5(33.3)

 

 Together

110(91.7)

94(88.7)

11(91.7)

16(94.1)

10(66.7)

 

smoking

     

0.159

 Yes

11(9.2)

6(5.7)

3(25.0)

1(5.9)

0(0.0)

 

 No

109(90.8)

100(94.3)

9(75.0)

16(94.1)

15(100.0)

 

drinking

     

0.110

 Yes

24(20.0)

12(11.3)

3(25.0)

2(11.8)

0(0.0)

 

 No

96(80.0)

94(88.7)

9(75.0)

15(88.2)

15(100.0)

 

Hypertension

     

0.003

 Yes

73(60.8)

69(65.1)

7(58.3)

3(17.6)

6(40.0)

 

 No

47(39.2)

37(34.9)

5(41.7)

14(82.4)

9(60.0)

 

Diabetes

     

0.618

 Yes

36(30.0)

32(30.2)

2(16.7)

3(17.6)

6(40.0)

 

 No

84(70.0)

74(69.8)

10(83.3)

14(82.4)

9(60.0)

 

Dyslipidemia

     

0.479

 Yes

68(56.7)

70(66.0)

6(50.0)

12(70.6)

10(66.7)

 

 No

52(43.3)

36(34.0)

6(50.0)

5(29.4)

5(33.3)

 

Hormone intake

     

0.162

 Yes

4(3.3)

2(1.9)

2(16.7)

0(0.0)

0(0.0)

 

 No

116(96.7)

104(98.1)

10(83.3)

17(100.0)

15(100.0)

 

Protein intake

     

0.217

 Yes

7(5.8)

7(6.6)

0(0.0)

2(11.8)

3(20.0)

 

 No

113(94.2)

99(93.4)

12(100.0)

15(88.2)

12(80.0)

 

Vitamin D intake

     

0.815

 Yes

19(15.8)

19(17.9)

2(16.7)

2(11.8)

4(26.7)

 

 No

101(84.2)

87(82.1)

10(83.3)

15(88.2)

11(73.3)

 

age

70(67,72)

72.5(68.0,77.0)

67.5(67.0,70.0)

73.0(70.5,77.5)

81.0(77.0,82.0)

< 0.001

height

164.0(158.0,170.0)

160.0(157.0,165.5)

160.0(157.3168.0)

158.0(153.0,161.0)

156.0(149.0,160.0)

< 0.001

weight

67.3(60.0,72.9)

68.3(59.8,76.7)

53.5(50.7,57.3)

53.4(49.7,60.9)

50.1(47.7,54.5)

< 0.001